Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Strong Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Amphastar Pharmaceuticals, Inc. (AMPH)

Pharmaceutical Preparations

http://www.amphastar.com

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

11570 SIXTH STREET
RANCHO CUCAMONGA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/25/2014

Market Cap

2,172,644,333

Shares Outstanding

47,910,000

Weighted SO

47,907,411

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

COLL --.--%

EGRX --.--%

ALKS --.--%

EOLS --.--%

NBIX --.--%

IRWD --.--%

ANIP --.--%

PBH --.--%

DCPH --.--%

Beta

0.7950

Last Div

0.0000

Range

36.56-65.92

Chg

-0.6850

Avg Vol

381480

Mkt Cap

2172644333

Exch

NASDAQ

Country

US

Phone

909 980 9484

DCF Diff

-54.4632

DCF

99.1932

Div Yield

0.0000

P/S

3.0477

EV Multiple

9.5789

P/FV

3.0602

Div Yield %

0.0000

P/E

13.1097

PEG

0.6829

Payout

0.0000

Current Ratio

3.5237

Quick Ratio

2.6300

Cash Ratio

1.3861

DSO

67.2829

DIO

134.7472

Op Cycle

202.0301

DPO

34.9772

CCC

167.0529

Gross Margin

0.5349

Op Margin

0.3225

Pretax Margin

0.2849

Net Margin

0.2336

Eff Tax Rate

0.1729

ROA

0.1116

ROE

0.2542

ROCE

0.1697

NI/EBT

0.8199

EBT/EBIT

0.8835

EBIT/Rev

0.3225

Debt Ratio

0.3963

D/E

0.8286

LT Debt/Cap

0.4514

Total Debt/Cap

0.4531

Int Coverage

38.7142

CF/Debt

0.3597

Equity Multi

2.0909

Rec Turnover

5.4249

Pay Turnover

10.4354

Inv Turnover

2.7088

FA Turnover

2.2238

Asset Turnover

0.4780

OCF/Share

4.3470

FCF/Share

3.6421

Cash/Share

4.5026

OCF/Sales

0.2982

FCF/OCF

0.8379

CF Coverage

0.3597

ST Coverage

50.0820

CapEx Coverage

6.1673

Div&CapEx Cov

6.1673

P/BV

3.0602

P/B

3.0602

P/S

3.0477

P/E

13.1097

P/FCF

12.1972

P/OCF

10.2680

P/CF

10.2680

PEG

0.6829

P/S

3.0477

EV Multiple

9.5789

P/FV

3.0602

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jan 15, 13:21 Centene (CNC) Sells Circle Health to Boost Managed Care Business Zacks Investment Research Jan 15, 13:21 Centene (CNC) Sells Circle Health to Boost Managed Care Business Zacks Investment Research Jan 01, 12:00 Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know Zacks Investment Research Dec 29, 14:06 Here's Why You Should Retain Centene (CNC) Stock For Now Zacks Investment Research Dec 26, 12:20 Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run? Zacks Investment Research Dec 26, 12:20 Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run? Zacks Investment Research Dec 26, 09:29 What Awaits These 4 Drug Stocks That More Than Doubled in 2023? Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock Zacks Investment Research Dec 25, 12:45 3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.30 06/11/2010 06/07/2010 11/30/-0001 06/30/2010
0.30 06/11/2009 06/05/2009 11/30/-0001 06/30/2009